LFUS insider notice: 13,210 shares to be sold via Merrill on 08/25/2025
Rhea-AI Filing Summary
Littelfuse Inc (LFUS) Form 144 notifies a proposed sale of 13,210 shares of common stock through Merrill on or about 08/25/2025. The filing lists an aggregate market value of $3,461,020.00 and reports 24,781,558 shares outstanding for the issuer. The shares to be sold were acquired over multiple dates primarily by restricted stock lapses between 2019 and 2025 and by stock option exercises in 2019 and 2020, with many restricted-lapse entries in April of each year. Broker details are provided as Merrill, 8890 Lyra Drive, Columbus, OH, 5th Floor. The filer certifies they are unaware of undisclosed material adverse information and no securities were reported sold by the filer in the past three months.
Positive
- Specified broker and sale date: Broker (Merrill) and approximate sale date (08/25/2025) are provided
- Complete acquisition history: Acquisition dates and transaction types (restricted stock lapse and option exercises) are listed for the securities to be sold
- Aggregate market value disclosed: Filing states aggregate market value of $3,461,020.00 for the shares to be sold
- Regulatory attestation included: Filer represents no undisclosed material adverse information and includes required signature/attestation language
Negative
- None.
Insights
TL;DR: Routine insider notice for a modest proposed sale; disclosure is complete and dated.
The Form 144 documents a proposed sale of 13,210 Littelfuse common shares via Merrill with an indicated aggregate market value of $3.46 million and 24.78 million shares outstanding reported. Acquisition history shows a mix of restricted stock lapses concentrated in April of multiple years and option exercises in 2019–2020. The filing includes the regulator-required attestation about no undisclosed material adverse information. Given the size of the proposed sale relative to outstanding shares (~0.053% of shares outstanding), the filing appears procedural rather than market-moving.
TL;DR: Proper Rule 144 compliance with clear acquisition provenance; no governance red flags in this filing.
The notice provides specific acquisition dates and transaction types (restricted stock lapse and option exercise) for all shares covered by the sale notice, satisfying transparency expectations for Rule 144 disclosures. Broker identity and an approximate sale date are provided. The filer’s signature section includes the standard attestation against undisclosed material adverse information. There are no statements here about trading plans or 10b5‑1 adoption, and no recent sales reported in the past three months.